Health & Nutrition
We're encouraged by Abbott stock trading but discouraged...
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon...
Merck beats earnings expectations, raises sales outlook...
The drugmaker raised its full-year sales forecast to $63.4 billion to $64.4 billion...
Pfizer beats earnings estimates, hikes full-year outlook...
The results come as Pfizer scrambles to stabilize its business and win back Wall...
Obesity and a Toxic Food Environment
Implausible explanations for the obesity epidemic serve the needs of food manufacturers...
We're making a flurry of moves: trimming 2 stocks and buying...
The trades come ahead of a busy week of earnings for the Investing Club portfolio.
An ugly earnings report from a competitor is good news...
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
Dexcom shares plunge more than 40% for worst day on record
Dexcom, which had its stock market debut in 2005, had its worst day ever after lowering...
Viking Therapeutics stock jumps nearly 30% after drugmaker...
It brings the drugmaker one step closer to joining the market for GLP-1s, which...
European drug regulator rejects Alzheimer's treatment Leqembi...
The committee said Leqembi's effect on delaying cognitive decline does not outweigh...
Dexcom shares plummet almost 40% after company misses on...
Dexcom issued disappointing results and guidance, which the company attributed in...
